Details for 2020215786

Up to date per 01.04.2026

Actions

Title / Product Name

PYRIDO[3',4':4,5]PYRROLO[1,2,3-DE]QUINOXALINDERIVAT ZUR BEHANDLUNG VON ERKRANKUNGEN DES ZNS

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2020215786

EP Publication Number

3838274

E-Number

1626437

Language

PCT Number

Publication Date

23.06.2021 A

01.11.2023 B1

Registration Date

01.11.2023

AT Publication Date

15.11.2023

Application Date

26.01.2017

Registration Number

Priorities

26.01.2016

201662287264 P

29.12.2016

201662440130 P

IPC

A61K 31/445 20060101AFI20210308BHEP

Maximum Duration of Protection

26.01.2037

Owner

Intra-Cellular Therapies, Inc.430 East 29th Street, Suite 900 New York, NY 10016US

Representative

No representatives present

Inventor

LI, PengIntra-Cellular Therapies, Inc. 430 East 29th Street, Suite 900 New York, New York 10016US

YAO, WeiIntra-Cellular Therapies, Inc. 430 East 29th Street, Suite 900 New York, New York 10016US

Information about Fees